Search Results

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

Thomas Equels

Showing 1-9 of about 9 articles.

Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. Meets Ampligen Sales Milestone in the 1st Quarter of 2017

about 114 days ago

Hemispherx Biopharma, Inc.

Hemispherx Outlines Key Elements of Strategic Growth Plan and Commitment to Transparency

about 349 days ago photo-release

Hemispherx Biopharma, Inc.

Hemispherx Biopharma Management Team: Reflects Company’s Aggressive Commitment to Strategies Designed to Reach Commercial Goals, Preserve Financial Capital, and Increase Stockholder Value

about 492 days ago photo-release

Hemispherx Biopharma, Inc.

Hemispherx Biopharma Receives the European Patent Office Grant of New Composition of Matter Patent Covering Ampligen(R) Formulations

about 639 days ago

Hemispherx Biopharma, Inc.

Photo Release -- Hemispherx Biopharma Fully Aligns Executive Bonus Programs to Accelerate Product Revenue Opportunities and Market Entry

about 667 days ago photo-release

Hemispherx Biopharma, Inc.

Hemispherx Expands Its Collaboration With Emerge Health for the Commercialization of Alferon in Australia and New Zealand

about 687 days ago

Hemispherx Biopharma, Inc.

Hemispherx Biopharma and Bioclones, a Leading South African Biotechnology Company, Join Forces on Novel Therapeutic Cancer Vaccine

about 1080 days ago

Hemispherx Biopharma, Inc.

Hemispherx Biopharma and Bioclones Join Forces in Effort to Eradicate HIV/AIDS Virus Based on Recent Clinical Insights of Wistar Institute, University of Pennsylvania

about 1086 days ago

Hemispherx Biopharma, Inc.

Hemispherx and GP Pharm Agree to Establish a Manufacturing Operation in Argentina to Serve Latin America Markets and Ancillary Markets

about 1134 days ago

Showing 1-9 of about 9 articles.

© 2017 GlobeNewswire, Inc. All Rights Reserved.